Postlethwaite; Arnold E.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Postlethwaite; Arnold E..The latest application filed is for "single nucleotide polymorphisms (snp) and association with resistance to immune tolerance induction".

Company Profile

2.8.13

Postlethwaite; Arnold E. - Eads TN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Single Nucleotide Polymorphisms (snp) And Association With Resistance To Immune Tolerance Induction App 20200149108 - Postlethwaite; Arnold E. ; et al.	2020-05-14
Single nucleotide polymorphisms (SNP) and association with resistance to immune tolerance induction Grant 10,450,610 - Postlethwaite , et al. Oc	2019-10-22
Single Nucleotide Polymorphisms (snp) And Association With Resistance To Immune Tolerance Induction App 20170016068 - Postlethwaite; Arnold E. ; et al.	2017-01-19
APLs for treating arthritis Grant 9,144,595 - Postlethwaite , et al. September 29, 2	2015-09-29
Single Nucleotide Polymorphisms (snp) And Association With Resistance To Immune Tolerance Induction App 20140286971 - Postlethwaite; Arnold E. ; et al.	2014-09-25
Enzymatic Production or Chemical Synthesis and Uses for 5,7-Dienes and UVB Conversion Products Thereof App 20140200201 - Slominski; Andrzej T. ; et al.	2014-07-17
Apls For Treating Arthritis App 20140113867 - Postlethwaite; Arnold E. ; et al.	2014-04-24
Methods Of Treating Fibrosing Diseases By Induction Of Immune Tolerance App 20140107035 - Postlethwaite; Arnold E. ; et al.	2014-04-17
Enzymatic Production or Chemical Synthesis and Uses for 5,7-Dienes and UVB Conversion Products Thereof App 20120258938 - Slominski; Andrej ; et al.	2012-10-11
Single Nucleotide Polymorphisms (snp) And Association With Resistance To Immune Tolerance Induction App 20120135014 - Postlethwaite; Arnold E. ; et al.	2012-05-31
Enzymatic production or chemical synthesis and uses for 5,7-dienes and UVB conversion products thereof App 20110118228 - Slominski; Andrzej ; et al.	2011-05-19
Methods Of Treating Fibrosing Diseases By Induction Of Immune Tolerance App 20100179096 - Postlethwaite; Arnold E. ; et al.	2010-07-15
Methods of treating fibrosing diseases by induction of immune tolerance Grant 7,718,765 - Postlethwaite , et al. May 18, 2	2010-05-18
Methods of treating fibrosing diseases by induction of immune tolerance App 20070142286 - Postlethwaite; Arnold E. ; et al.	2007-06-21
Chemotactic wound healing peptides Grant 5,824,647 - Postlethwaite , et al. October 20, 1	1998-10-20
Chemotactic wound healing peptides Grant 5,436,228 - Postlethwaite , et al. July 25, 1	1995-07-25
Fragment of TNF-.alpha. for promoting wound healing Grant 5,160,483 - Postlethwaite , et al. November 3, 1	1992-11-03
Somnogenic fragment of interleukin-1.beta. Grant 5,075,288 - Krueger , et al. December 24, 1	1991-12-24

Company Registrations

NCAGE Code	4RJ80	POSTLETHWAITE, ARNOLD E
CAGE Code	4RJ80	POSTLETHWAITE, ARNOLD E
DUNS	789956542	POSTLETHWAITE, ARNOLD E

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.